Overview
Desmoplakin is a 250-330 kDa cytoplasmic protein essential for desmosome assembly, acting as the primary linker between the desmosomal cadherin complex and intermediate filaments. As the most abundant desmosomal component, it exists in two major splice variants (DPI and DPII) with distinct functional roles. Its modular structure includes plakin domains for intermediate filament binding and coiled-coil regions for dimerization. First identified in 1983, desmoplakin's critical role in maintaining epithelial and cardiac tissue integrity has made it a focus of research in genetic disorders like arrhythmogenic cardiomyopathy and skin blistering diseases. Over 200 pathogenic mutations have been documented in clinical genetics databases.
Physical and Chemical Properties
As a large dimeric protein, desmoplakin exhibits unique biophysical characteristics. The full-length DPI isoform contains 2,871 amino acids with three major domains: an N-terminal plakin domain for plaque association, a central coiled-coil rod domain mediating dimerization, and C-terminal plakin repeat domains (PRDs) for intermediate filament binding. Its isoelectric point is approximately 6.2. The protein demonstrates remarkable mechanical stability, withstanding forces up to 100 pN during cell adhesion. Post-translational modifications include phosphorylation at Ser2849 by PKCα, which regulates its interaction with intermediate filaments. Recombinant forms typically show >90% purity by SDS-PAGE and maintain activity when stored at -80°C in lyophilized form.
Main Applications
In biomedical research, desmoplakin serves as a key marker for desmosome integrity studies. Its antibodies are routinely used in immunohistochemistry to diagnose skin disorders like pemphigus vulgaris and genetic cardiomyopathies. Knockout mouse models demonstrate its necessity for embryonic development, particularly in heart and skin formation. Therapeutic applications focus on gene therapy for DSP-linked arrhythmogenic cardiomyopathy (ARVC), where over 4% of cases involve desmoplakin mutations. Researchers also utilize recombinant desmoplakin fragments to study protein-protein interactions in desmosome assembly, with particular interest in its binding to plakoglobin and desmocollin.
Safety and Storage
Laboratory-grade desmoplakin preparations require standard biosafety level 1 handling. While non-toxic in purified forms, inhalation of lyophilized powder should be avoided. Recombinant proteins should be reconstituted in sterile PBS or Tris buffers (pH 7.4-8.0) with protease inhibitors to prevent degradation. Long-term storage at -80°C in single-use aliquots prevents freeze-thaw damage. Working solutions remain stable for 1 week at 4°C when containing 0.1% BSA as a stabilizer. For antibody production, immunization-grade peptides should be stored dessicated at -20°C with desiccants to maintain integrity.
B2B Procurement Guide
When sourcing desmoplakin reagents, verify the specific isoform (DPI contains additional exons compared to DPII) and species reactivity (human vs mouse). Research-grade recombinant proteins typically cost $200-800/mg depending on purity (≥90% preferred for structural studies) and tag configuration (His-tag vs GST). Leading suppliers include Sigma-Aldrich (antibodies), Abcam (recombinant fragments), and Proteintech (full-length clones). Bulk orders (10+ mg) may qualify for 15-30% discounts. For clinical applications, ensure products meet IVD certification standards. Always request COA documents detailing endotoxin levels (<1 EU/μg) and functional validation data.